Why Itron (ITRI) Outpaced the Stock Market Today

Itron (ITRI) closed up 1.48% in its latest session, outperforming the S&P 500, yet it has lagged the broader market over the past month with a 2.47% loss. The company is scheduled to report earnings on February 25, 2025, with consensus estimates projecting a 14.63% year-over-year decline in EPS to $1.05, despite a forecasted 4.52% revenue increase to $603.26 million. Analyst EPS estimates have seen a slight 0.74% downward revision over the last 30 days, leading to a Zacks Rank of #3 (Hold), while the stock trades at a Forward P/E of 21.89 and a PEG ratio of 0.88, both at a discount to its industry averages.

Analysis

Itron (ITRI) presents a mixed financial profile ahead of its upcoming earnings report. While the stock's recent daily performance of +1.48% outpaced major indices, its one-month return shows a 2.47% loss, lagging both the S&P 500 and its own technology sector. The primary point of concern for investors is the divergence in forward-looking estimates for the quarter ending February 25, 2025. Consensus forecasts project a 4.52% year-over-year increase in revenue to $603.26 million, but a significant 14.63% decline in EPS to $1.05, signaling potential margin compression or rising operational costs. This cautious outlook is reinforced by a 0.74% downward revision in the Zacks Consensus EPS estimate over the past 30 days, contributing to its current Zacks Rank of #3 (Hold). On a valuation basis, however, the stock appears attractive relative to its peers. Its Forward P/E ratio of 21.89 is below the industry average of 24.99, and its PEG ratio of 0.88 is substantially lower than the industry's 2.41, suggesting the stock may be undervalued relative to its expected growth. This is further supported by a strong Zacks Industry Rank in the top 36%, indicating a generally favorable industry environment.

Key Decisions for Investors

• Investors should exercise caution ahead of the February 25 earnings release, as the projected 14.63% year-over-year EPS decline, despite revenue growth, flags a significant risk of margin pressure that could negatively impact the stock price.
• The current valuation, highlighted by a discounted Forward P/E and a low PEG ratio of 0.88, presents a potential value case, but this must be weighed against the negative sentiment reflected in recent downward analyst estimate revisions and the neutral #3 (Hold) rating.
• Monitor the upcoming earnings report for management's commentary on the causes behind the revenue and profit divergence, as any guidance on future profitability will be critical in resolving the conflicting signals presented by its valuation and near-term earnings outlook.